Decoy Therapeutics Inc.
DCOY· Nasdaq
DCOYDecoy Therapeutics Inc.
Filed Mar 27, 2023 · 10-K · 86 days after period end · 0001615219-23-000030
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $1.48M | $1.04M |
| Net Income | -$6.37M | -$4.10M | -$1.77M | -$1.88M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 27, 2023 · 86 d after period end
